Alliance Global Partners assumed coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $1.85 price objective on the biotechnology company’s stock. A number of other analysts have also recently issued reports on EVGN. StockNews.com began coverage on Evogene […]
Evogene (NASDAQ:EVGN) Now Covered by Alliance Global Partners theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Evogene (TSE:EVGN – Get Free Report) had its target price cut by stock analysts at Desjardins from C$4.50 to C$4.25 in a report issued on Monday, BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Evogene Stock Performance About Evogene (Get Free Report) Evogene is a leading computational biology company focused on […]
Evogene (NASDAQ:EVGN – Free Report) had its target price lifted by Lake Street Capital from $2.00 to $3.00 in a research note released on Friday morning, MarketBeat.com reports. They currently have a buy rating on the biotechnology company’s stock. EVGN has been the topic of several other research reports. StockNews.com initiated coverage on Evogene in […]
Evogene (NASDAQ:EVGN – Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.02, MarketWatch Earnings reports. Evogene had a negative return on equity of 67.44% and a negative net margin of 943.25%. The firm had […]